Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nahum Méndez-Sánchez"'
Publikováno v:
Liver International. 42:2903-2906
Metabolic (dysfunction)-associated fatty liver disease has taken importance during the last two years, given the new criteria for diagnosis compared to the previous criteria used to define non-alcoholic fatty liver disease. Multiple studies have also
Autor:
Hugo A. Hernández-Pérez, Sofia Moran-Ramos, Hugo Villamil-Ramírez, Elena Larrieta-Carrasco, Joel Vega-Badillo, Itzel Fernández-Silva, Teresa Villarreal-Molina, Fausto Sánchez-Muñoz, Paola León-Mimila, Rogelio Hernández-Pando, Carlos A. Aguilar-Salinas, Nahum Méndez-Sánchez, Roxana Gutiérrez-Vidal, Francisco Campos-Pérez, Samuel Canizales-Quinteros, Armando R. Tovar
Publikováno v:
Liver International. 36:1383-1391
Background and aim Abnormal cholesterol metabolism may contribute to the pathogenesis of non-alcoholic steatohepatitis (NASH) and fibrosis. miR-33 and miR-144 regulate adenosine triphosphate binding cassette transporter (ABCA1) and other target genes
Autor:
Julio A Pérez-Sosa, Jezer I. Lezama-Mora, Daniel Zamora-Valdés, José A. Flores-Rangel, Genaro Vazquez-Elizondo, Nahum Méndez-Sánchez, Francisco Vásquez-Fernández, Guadalupe Ponciano-Rodríguez, Misael Uribe, Martha H. Ramos
Publikováno v:
Liver International. 28:402-406
Background/Aims: Gallstone disease (GD) and cardiovascular disease (CD) are common diseases worldwide with considerable economical impact and they are strongly associated. Carotid atherosclerosis is an excellent marker of risk for CD like stroke and
Autor:
Blanca A Barredo-Prieto, Misael Uribe, Nahum Méndez-Sánchez, Héctor Baptista-González, Daniel Zamora-Valdés, Guadalupe Ponciano-Rodríguez, Luisa Bermejo-Martínez, Norberto C. Chávez-Tapia, Raúl Pichardo-Bahena
Publikováno v:
Liver International. 27:215-219
Background and Aim: Fatty infiltration and fibrosis are major issues in chronic liver disease. Recent reports suggest a role for the endocannabinoid system in these processes. Aim: To characterize localization and expression of CB2 in normal liver an
Publikováno v:
Liver International. :070901081846003
Nonalcoholic fatty liver disease (NAFLD) is a chronic illness with multiple consequences. The spectrum of disease ranges from simple steatosis, with benign prognosis, to a potentially progressive form, nonalcoholic steatohepatitis, which may lead to